Delivery Order SPE2DB24D8001-SPE2DB24FKZAG

Award Date 9/9/24
Potential Completion Date 9/10/24
Potential Value $5.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a $4,814.07 firm fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of Trulicity 0.75 mg/0.5 ml pens. This contract is associated with Dakota Drug, Inc.'s $999,999,999.00 Indefinite Delivery Contract (IDC) under the DLA Troop Support Medical's ECAT Generation V Program, which enables the company to provide a broad range of pharmaceutical products, medical supplies, and healthcare...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $1,378.16 to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML pharmaceutical products. This order is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division under the ECAT Generation V Program, which has a potential value of $999,999,999.00 and a performance period...
The Defense Logistics Agency (DLA) awarded a $1,340.67 firm fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the provision of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. This delivery order is part of a larger $999,999,999.00 single-award Indefinite Delivery Contract (IDC) held by Dakota Drug, Inc. under the DLA Troop Support Medical's ECAT Generation V Program, which procures commercial medical equipment, accessories,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $1,896.78, is for the delivery of Trulicity 1.5 mg/0.5 ml pens to support medical operations of the U.S. Armed Forces. The contract falls under the DLA Troop Support Medical's ECAT Generation V Program, which procures commercial medical equipment, accessories, consumables, and medical simulation equipment...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract worth $1,312.08 to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of TRULICITY 4.5 MG/0.5 ML PEN 0.5ML. This delivery order is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) worth $999,999,999.00 with the DLA Troop Support Medical under the ECAT Generation V Program, which allows the company to provide a wide range of pharmaceutical products,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit Subchapter S corporation. The contract, valued at $2,882.20, is for the delivery of Trulicity 1.5 mg/0.5 ml pens. This order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, valued at $999,999,999.00, which allows Dakota Drug, Inc. to provide a...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $1,661.99 to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a prescription medication used to treat diabetes. This delivery order falls under Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V...
The Defense Logistics Agency (DLA) awarded a $1,683.28 firm fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML. This order was issued under Dakota Drug's $999,999,999.00 indefinite delivery contract (SPE2DB24D8001) with the DLA Troop Support Medical, which supports the procurement of commercial medical equipment, accessories, consumables, and simulation equipment for the U.S. Armed...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of Trulicity 0.75 mg/0.5 ml pens. The contract has a firm fixed price of $2,566.28 and a performance period ending on January 6, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00, which allows Dakota Drug, Inc. to provide a range of pharmaceutical products, medical supplies, and healthcare...
This contract award was made by the Defense Logistics Agency (DLA), a defense agency, to Dakota Drug, Inc., a self-certified small disadvantaged business. The $1,505.02 Firm Fixed Price Delivery Order contract is for the supply of Trulicity 3 mg/0.5 ml pen 0.5 ml, a prescription pharmaceutical product. The contract has an ultimate completion date of October 23, 2024. This award is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00,...
  • SPE2DB24D8001
    Indefinite Delivery Contract
  • SPE2DB24D8001-SPE2DB24FKZAG
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Dakota Drug, Inc., a small disadvantaged business, to provide 0.75 mg/0.5 ml Trulicity pen injectors. The $5,293.36 contract is part of the DLA Troop Support Medical's ECAT Generation V Program, which procures commercial medical equipment and supplies. This single-award Indefinite Delivery Contract (IDC) with Dakota Drug, Inc., valued at $999,999,999.00, allows the DLA to efficiently acquire a wide range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. The contract has no set-aside designation and is effective through September 10, 2024.

Generated 12/9/24, 1:47 PM